Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iltamiocel in Female Participants With Chronic Fecal Incontinence (DigniFI)
NCT05776277Phase 3Active, not recruiting
- Sponsor
- Cook MyoSite
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of AMDC-USR in fecal incontinence (FI), sponsored by Cook MyoSite. Started Mar 2024; status: active, not recruiting.
02
Drugs
AMDC-USR
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT05776277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05776277.